Living With Mastocytosis: Expert Guidance

This episode was recorded prior to Anaphylaxis UK's merger with Allergy UK. Please be aware that we are now one charity under the name Allergy UK incorporating Anaphylaxis UK. People with Systemic Mastocytosis (SM) have an increased risk of developing serious and life-threatening allergic reactions, which are often unpredictable. The prevalence of SM is low – approximately 1-2 people per 10,000 population – which means clinicians may not be familiar with it and may not consider it in cases of anaphylaxis, nor recognise the different presentation and importance of timely treatment of anaphylaxis in people with SM. This podcast sheds light on SM and anaphylaxis with the of help of Dr Andrew Whyte (Consultant Allergist and Immunologist, University Hospitals Plymouth NHS Trust), Jess Hobart (Chair of UKMasto.org - a charity supporting people diagnosed with Mastocytosis), & Charlotte Lane sharing her lived experience as a parent navigating the daily realities of the condition. You can now download our free PIFTICK accredited factsheet on systemic mastocytosis and its link with anaphylaxis: https://anaphylaxis.org.uk/factsheets... For help and support, please visit UKMasto.org's Facebook support page:   / ukmasto   This podcast has been sponsored by Blueprint Medicines, a Sanofi company, in compliance with industry code of practice. Blueprint Medicines has had no input into or editorial control over the content, development, or delivery of this initiative. ------- Interesting in allergy training? See our AllergyWise® online courses: https://www.anaphylaxis.org.uk/allerg... Follow us on: Instagram: anaphylaxisuk Facebook:   / anaphylaxisuk   LinkedIn: linkedin.com/company/anaphylaxis-uk We are registered with the Fundraising Regulator. Allergy UK incorporating Anaphylaxis UK. Charity No: 1094231. Company No: 4509293. Registered in Scotland - Charity No: SC039257.